Anhui Huangshan Capsule Past Earnings Performance
Past criteria checks 2/6
Anhui Huangshan Capsule has been growing earnings at an average annual rate of 7.5%, while the Chemicals industry saw earnings growing at 4.3% annually. Revenues have been growing at an average rate of 9.1% per year. Anhui Huangshan Capsule's return on equity is 5.4%, and it has net margins of 10.4%.
Key information
7.5%
Earnings growth rate
7.3%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 9.1% |
| Return on equity | 5.4% |
| Net Margin | 10.4% |
| Next Earnings Update | 26 Apr 2025 |
Recent past performance updates
Recent updates
Anhui Huangshan Capsule Co., Ltd. (SZSE:002817) Investors Are Less Pessimistic Than Expected
Sep 30
Anhui Huangshan Capsule's (SZSE:002817) Shareholders Have More To Worry About Than Only Soft Earnings
Aug 28Returns On Capital Are Showing Encouraging Signs At Anhui Huangshan Capsule (SZSE:002817)
Jun 06Anhui Huangshan Capsule Co., Ltd.'s (SZSE:002817) 26% Price Boost Is Out Of Tune With Earnings
Mar 08Revenue & Expenses Breakdown
How Anhui Huangshan Capsule makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 24 | 473 | 49 | 61 | 14 |
| 30 Sep 24 | 454 | 50 | 59 | 15 |
| 30 Jun 24 | 442 | 57 | 55 | 14 |
| 31 Mar 24 | 438 | 60 | 59 | 15 |
| 01 Jan 24 | 463 | 65 | 62 | 16 |
| 30 Sep 23 | 483 | 68 | 62 | 15 |
| 30 Jun 23 | 476 | 67 | 64 | 16 |
| 31 Mar 23 | 470 | 67 | 57 | 16 |
| 01 Jan 23 | 428 | 61 | 55 | 15 |
| 30 Sep 22 | 403 | 62 | 54 | 13 |
| 30 Jun 22 | 392 | 62 | 55 | 14 |
| 31 Mar 22 | 377 | 60 | 57 | 14 |
| 31 Dec 21 | 380 | 57 | 59 | 13 |
| 30 Sep 21 | 382 | 54 | 52 | 14 |
| 30 Jun 21 | 372 | 53 | 55 | 12 |
| 31 Mar 21 | 353 | 47 | 57 | 10 |
| 31 Dec 20 | 319 | 45 | 57 | 9 |
| 30 Sep 20 | 304 | 41 | 74 | 10 |
| 30 Jun 20 | 312 | 40 | 74 | 11 |
| 31 Mar 20 | 318 | 39 | 76 | 12 |
| 31 Dec 19 | 326 | 39 | 74 | 13 |
| 30 Sep 19 | 320 | 39 | 64 | 16 |
| 30 Jun 19 | 305 | 34 | 62 | 15 |
| 31 Mar 19 | 297 | 34 | 57 | 15 |
| 31 Dec 18 | 295 | 36 | 57 | 13 |
| 30 Sep 18 | 286 | 37 | 56 | 8 |
| 30 Jun 18 | 284 | 40 | 48 | 15 |
| 31 Mar 18 | 285 | 44 | 49 | 12 |
| 31 Dec 17 | 286 | 46 | 51 | 10 |
| 30 Sep 17 | 289 | 47 | 56 | 9 |
| 30 Jun 17 | 290 | 47 | 64 | 0 |
| 31 Mar 17 | 290 | 50 | 63 | 0 |
| 31 Dec 16 | 283 | 52 | 60 | 0 |
| 31 Dec 15 | 254 | 55 | 49 | 0 |
| 31 Dec 14 | 273 | 52 | 50 | 0 |
Quality Earnings: 002817 has high quality earnings.
Growing Profit Margin: 002817's current net profit margins (10.4%) are lower than last year (14%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002817's earnings have grown by 7.5% per year over the past 5 years.
Accelerating Growth: 002817's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 002817 had negative earnings growth (-24.1%) over the past year, making it difficult to compare to the Chemicals industry average (-0.08%).
Return on Equity
High ROE: 002817's Return on Equity (5.4%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/24 21:15 |
| End of Day Share Price | 2025/04/24 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Anhui Huangshan Capsule Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.